COVID19 - competitive landscape, page-356

Throughout 2019 the company had made ref to discussions with several big Pharma companies are ongoing that tells me there is obviously interest in our technology or is MM lying to her SH???? The fact the decision was made to run another clinical trial now we are better equipped new tools at our disposal a better understanding to analyse the results doesn’t in anyway suggest to me we are clutching at straws lol quite the opposite hence MM stating significant value has been created……or is it she is lying to her SH lol lol